Vitamin K antagonists and cancer: Rebuttal (multiple letters) [17]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 2, 2004, Pages 377-378

  Schulman, Sam ^a   Lindmarker, P ^a   Taliani, M R ^b   Agnelli, Giancarlo ^b   Prandoni, P ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR 7A; GELATINASE A; THROMBOPLASTIN; WARFARIN; VITAMIN K GROUP;

ANAMNESIS; ANTICOAGULATION; ANTINEOPLASTIC ACTIVITY; CANCER; CANCER PREVENTION; COMPLEX FORMATION; ENZYME RELEASE; EXPERIMENTAL DESIGN; FOLLOW UP; HUMAN; INCIDENCE; LETTER; PRIORITY JOURNAL; PROBABILITY; SAMPLE; STATISTICAL SIGNIFICANCE; VENOUS THROMBOEMBOLISM; VITAMIN K DEFICIENCY; DRUG ANTAGONISM; METHODOLOGY; NEOPLASM; NOTE; PATIENT SELECTION;

HUMANS; NEOPLASMS; PATIENT SELECTION; RESEARCH DESIGN; VITAMIN K; WARFARIN;

EID: 13244271991     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7933.2004.0584t.x     Document Type: Letter

References (0)